Gastro + Endo + Nephro Flashcards
H pylori post eradication therapy
Consider retest if:
- poor compliance to eradication therapy
- Aspirin or NSAID is indicated
- FHx of gastric malignancy
- The person requests re-testing
They advise that re-testing should ideally be done 8 weeks after initial eradication therapy and the carbon-13 urea breath test should be used first-line.
GI bleed scoring system
blatchford bleeding risk
rockall rebleeding risk
1st-3rd line therapy c diff
first-line therapy is oral vancomycin for 10 days
second-line therapy: oral fidaxomicin
third-line therapy: oral vancomycin +/- IV metronidazole
C peptide and type 1 vs type 2 diabetes?
C peptides raised in type 2
Prolactinoma treatment
Dopamine agonist (e.g cabergoline, bromocriptine)
surgery if fail to respond
acromegaly and elevated IGF-1 (insulin growth factor) investigations
OGTT and serial GH levels
acromegaly how to diagnose
1st = serum IGF-1
2nd= OGTT+ serial GH
in normal patients if hyperglycaemic then GH reduced, but in acromegaly GH still high
what marker monitors disease In acromegaly
IGF-1
crushing syndrome metabolic disturbance
hypokalaemia metabolic alkalosis
Bicarbonate resorption is increased in the tubules with potassium depletion causing metabolic alkalosis.
Gynaecomastia causes: drugs
spironolactone (most common drug cause)
cimetidine
digoxin
cannabis
finasteride
GnRH agonists e.g. goserelin, buserelin
oestrogens, anabolic steroids
Treatment for galactorrhoea
bromocriptine (dopamine agonist)
how do thiazides impact Ca level
HYPERcalacemia
what is subclinical hypothyroid
TSH above range but normal thyroxine
Subclinical hypothyroidism with TSH level of level is 5.5 - 10mU/L: offer patients < 65 years a 6-month trial of thyroxine if TSH remains at that level on 2 separate occasions 3 months apart and they have hypothyroidism symptoms
what medication interacts with thyroxine absorption
iron
Kallman’s syndrome hormone level
low LH & FSH and testosterone (failure of GnRH secreting neurones in hypothalamus)
Kallman = Fallman
Poor Kall the man cannot smell
chromosome = X linked drecessive
Klinefelter Sx
High FSH and high LH. But low testosterone. Tall, no secondary sexual characteristics. Small firm testes + gynecomastia.
Addisons and hyperpigmentation
primary Addison’s is associated with hyperpigmentation whereas secondary adrenal insufficiency is not
secondary causes= tumours, irradiation, infiltration, exogenous steroids
Diabetes-specific autoantiboits T2DM vs T1DM
in type 1 C peptide LOW but others present
OGTT test: IMPAIRED glucose tolerance
Fasting plasma glucose < 7.0 mmol/l
OGTT 2-hour value: 7.8 to 11.1 mmol/l
drug causes raised prolactin (and –> galacctoreoa)
metoclopramide, domperidone
phenothiazines
haloperidol
very rare: SSRIs, opioids
non drug causes raised prolactin
prolactinoma
pregnancy
oestrogens
physiological: stress, exercise, sleep
acromegaly: 1/3 of patients
polycystic ovarian syndrome
primary hypothyroidism (due to thyrotrophin releasing hormone (TRH) stimulating prolactin release)
T1DM with bloating, vomiting and erratic CGMs? what med to try
metoclopramide
tender goitre, hyperthyroidism and raised ESR. The globally reduced uptake on technetium thyroid scan is also typical
Sub acute (De Quervains) thyroiditis
diabetes medicaition and BMI>35 - what to consider?
GLP-1 (e.g. exenatide)
FOR SPECIALSITS ONLY
GLP-1 receptor agonists should only be continued if there is a reduction of at least 11 mmol/mol [1.0%] in HbA1c and a weight loss of at least 3% of initial body weight in 6 months.
Who avoids SGLT-2?
FOOT ULCER
should be avoided in active foot disease (such as skin ulceration, osteomyelitis, or gangrene) due to the possible increased risk of lower limb amputation (mainly toes).
T2DM triple therapy not worked.. what to do?
if a triple combination of drugs has failed to reduce HbA1c then switching one of the drugs for a GLP-1 mimetic is recommended, particularly if the BMI > 35
most common cause of cushings SYDNROME
pituitary adeoma (aka cushings DISEASE) - ACTH
Thiazolinediones - what is the the side effects?
e.g. Pioglitazone
T2DM medication
weight gain
liver impairment
fluid retention –. CONTRAINDICATED in hearty failure
increased fractures
bladder cancer
which diabetic meds cause weight gain
gliclazide and prioglitazone
thyrotoxicosis with tender goitre
de Quervains thyroiditis
Addisons and vomiting
take IM hydrocortisone until vomiting stops
hypoglycaemia - what two things to measure to investigate cause? (2)
What does this show? (2)
Serum insulin and C-peptite
Insulin HIGH C peptide HIGH = endogenous insulin production (insulinoma/ sulfonylrea)
Insulin HIGH C peptide LOW = exogenous (added too much)
Insulin Low C peptide LOW = non inulin cause e.g. alcohol, critical illness, adrenal insufficient, GH deficiency, fasting/ starvation
a HbAlc value of less than 48 mmol/mol (6.5%)
does not exclude diabetes (i.e. it is not as sensitive as fasting samples for detecting diabetes) –> consider fasting glucose sample
T4 vs T3
T4 is the synthetic form
raised ESR
AUTOIMMUNE CONDITIONS e.g. hashimotos thyroiditis
Addisons - high or low aldosteronism
PRIMARY HYPOaldosteronism
hypercalacemia- two most common causes
malignancy and PTH
-> PTH best test for confimin diagnosis
e.g. if PTH raised or normal = Primary hyperparathyroidism
PTHrP tumour
squamous cell lung cancer
how do sulfonyluyrea work
bind to an ATP-dependent K+(KATP) channel on the cell membrane of pancreatic beta cells
–> insulin release
(hence why you get weight gain)
Crohns:
how to induce remission (3)
fistulating disease (1)
peri-anal disease (1)
what diet? (1)
1st line - glucocorticoids (budesonide as alternative)
THEN
2nd line - 5-ASA drugs (e.g. mesalazine)
3rd line= azathioprine or mercaptopurine as add on
fistulating/ reflractory= inflixamab
peri-anal disease= metronidazole
diet= enteral feeding with an elemental diet may be used in addition to or instead of other measures to induce remission, particularly if there is concern regarding the side-effects of steroids (for example in young children)
Crohns:
maintaining remission? (1)
smoking: what to do? (1)
perianal disease (3)
azathioprine or mercatopurine
stop smoking
peri-anal disease: MRI
metronidazole
anti-TNF (infliximab)
draining seton for complex
Crohns:
common complications (3)
small bowel cancer
colorectal cancer
osteoporosis
Diarrhoea:
acid-base balance seen on arterial blood gas?
Normal anion gap metabolic acidosis
diarrhoea= loose bicarbonate = loose alkaloid ions = blood is acidotic
It is a normal anion gap as acidosis is not a result of acidotic ion production, such as lactate, ketosis, or salicylate acid.
Causes of anion gap metabolic acidosis
lactate (shock, sepsis, hypoxia)
ketones: diabetic ketoacidosis
alcohol
urate: renal failure
acid poisoning: salicylates, methanol
Iron studies:
how to tell difference between deficiency anaemia vs. anaemia of chronic disease (1)
TIBC is high in IDA, and low/normal in anaemia of chronic disease
ACD:
normochromic/hypochromic, normocytic anaemia
reduced serum and TIBC
normal or raised ferritin
- TIBC measures the number of binding sites on transferrin available for iron. It therefore also increases in ID and decreases in ACD.
Transferrin: how does it change in iron deficiency
- Transferrin is the body’s carrier of iron around the blood. In states of iron deficiency, transferrin increases as the body tries to ‘make the most’ of what iron it has left, meaning that transferrin levels go up.
- Anaemia of chronic disease is the body’s physiological response to a danger, such as a potentially harmful pathogen. Like humans, pathogens require iron for metabolism and survival. Therefore, in ACD, the body reduces iron available for pathogens by circulating less around the blood. This means that transferrin decreases.
- TIBC measures the number of binding sites on transferrin available for iron. It therefore also increases in ID and decreases in ACD.
Iron studies:
when is ferritin high/low? (2)
high= inflammatory disorders
low= IDA
Which Abx causes C diff? (1)
what other drug linked to it? (1)
Clindamycin
PPI !
C diff:
distinguishing features for severe/ life threatening? (2)
severe:
increased WCC, temperature
life threatening:
hypotension, partial/complete ileus, toxic megacolon
C diff:
diagnosis (1)
is made by detecting C. difficile toxin (CDT) in the stool
C. difficile antigen positivity only shows exposure to the bacteria, rather than current infection
C diff: 1st/2nd/3rd management (3)
if recurrent (2)
life-threatening (1)
first-line therapy is oral vancomycin for 10 days
second-line therapy: oral fidaxomicin
third-line therapy: oral vancomycin +/- IV metronidazole
Recurrent episode
recurrent infection occurs in around 20% of patients, increasing to 50% after their second episode
within 12 weeks of symptom resolution: oral fidaxomicin
after 12 weeks of symptom resolution: oral vancomycin OR fidaxomicin
Life-threatening C. difficile infection
oral vancomycin AND IV metronidazole
specialist advice - surgery may be considered
flushing, diarrhoea, bronchospasm, hypotension, and weight loss.
carcinoid tumor
5-HIAA (the tumor will serete serotonin)
usually occurs when metastases are present in the liver and release serotonin into the systemic circulation
may also occur with lung carcinoid as mediators are not ‘cleared’ by the liver
Coagulopathy:
all clotting factors are low except for factor VIII. Both PT and APTT prolonged.
liver failure
Coagulopathy:
VIII low only (1)
IX low only (1)
Haemophilia A
Haemophilia B
Diabsts insipidus: causes
either ADH decreased secretion from pituitary OR insensitivity to ADH
idiopathic
post head injury
pituitary surgery
craniopharyngiomas
infiltrative
histiocytosis X
sarcoidosis
DIDMOAD is the association of cranial Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness (also known as Wolfram’s syndrome)
haemochromatosis
Pernicious anaemia:
which Vitamin? (1)
other causes of deficiency (3)
diagnosis (1)
B12
Other causes include atrophic gastritis (e.g. secondary to H. pylori infection), gastrectomy, malnutrition (e.g. alcoholism)
Anti intrinsic factor antibodies
Pernicious anemaia: feature
anaemia features
lethargy
pallor
dyspnoea
neurological features
peripheral neuropathy: ‘pins and needles’, numbness. Typically symmetrical and affects the legs more than the arms
subacute combined degeneration of the spinal cord: progressive weakness, ataxia and paresthesias that may progress to spasticity and paraplegia
neuropsychiatric features: memory loss, poor concentration, confusion, depression, irritabiltiy
other features
mild jaundice: combined with pallor results in a ‘lemon tinge’
atrophic glossitis → sore tongue
Pernicious anaemia management
Management
vitamin B12 replacement
usually given intramuscularly
no neurological features: 3 injections per week for 2 weeks followed by 3 monthly treatment of vitamin B12 injections
more frequent doses are given for patients with neurological features
there is some evidence that oral vitamin B12 may be effective for providing maintenance levels of vitamin B12 but it is not yet common practice
folic acid supplementation may also be required
A BMI >30 kg/m², increased hepatic echogenicity on liver ultrasound, and an ALT:AST ratio >2
NAFLD
Barretts:
management
high-dose proton pump inhibitor
whilst this is commonly used in patients with Barrett’s the evidence base that this reduces the change of progression to dysplasia or induces regression of the lesion is limited
endoscopic surveillance with biopsies
for patients with metaplasia (but not dysplasia) endoscopy is recommended every 3-5 years
if dysplasia of any grade is identified endoscopic intervention is offered. Options include:
radiofrequency ablation: preferred first-line treatment, particularly for low-grade dysplasia
endoscopic mucosal resection
Haemochromatosis:
how inherited?
how to monitor (1)
why is serum iron useless (1)
Autosomal recessive
Ferritin and transferrin saturation
ferritin is a measure of total iron stores, and transferrin saturation also measures how much serum iron is bound to proteins in the blood.
Similarly, serum iron fluctuates throughout the day and is based on diet. Furthermore, it is likely to fluctuate significantly with regular phlebotomies.
CKD on haemodialysis:
most likely cause of death (1)
causes (5)
IHD
diabetes
chronic glomerulonephritis
chronic pyelonephritis
HTN
adult PCKD
Granulomas: Crohns vs UC
Crohns
Pseudopolyps: Crohns vs UC
UC
Skip lesions: Crohns vs UC
Crohns
Goblet cells + granulomas: Crohns vs US
Crohns
Primary sclerosing cholangitis more common: C vs UC
UC
Gallstones are more common secondary to reduced bile acid reabsorption
Oxalate renal stones*: Crohns Vs UC
CrohnsWidespread ulceration with preservation of adjacent mucosa which has the appearance of polyps (‘pseudopolyps’)
Widespread ulceration with preservation of adjacent mucosa which has the appearance of polyps (‘pseudopolyps’)
UC
Radiology results UC vs Crohns
Crohns: Small bowel enema
high sensitivity and specificity for examination of the terminal ileum
strictures: ‘Kantor’s string sign’
proximal bowel dilation
‘rose thorn’ ulcers
fistulae
UC: loss of haustrations
superficial ulceration, ‘pseudopolyps’
long standing disease: colon is narrow and short -‘drainpipe colon’
Mild/ moderate/ severe UC: diarrhoea
mild: < 4 stools/day, only a small amount of blood
moderate: 4-6 stools/day, varying amounts of blood, no systemic upset
severe: >6 bloody stools per day + features of systemic upset (pyrexia, tachycardia, anaemia, raised inflammatory markers)
UC: mild-moderate disease
how to induce remission
1st LINE: RECTAL +/- LEFT SIDED
topical (rectal) aminosalicylate
if remission not achieved in 4 weeks add oral
if still not achieved add steroids oral
1st LINE: EXTENSIVE (RIGHT SIDED)
topical (rectal) and high dose oral aminosalicylate
UC: severe disease remission
HOSPITAL for IV steroids 1st line
UC: maintenance
aminosalicylate
Following a severe relapse or >=2 exacerbations in the past year
oral azathioprine or oral mercaptopurine
Other points
methotrexate is not recommended for the management of UC (in contrast to Crohn’s disease)
there is some evidence that probiotics may prevent relapse in patients with mild to moderate disease
Diagnosis of non-alcoholic fatty liver diseases
Enhanced liver fibrosis blood test
H pylori test:
when to stop meds before urea breath test
4 weeks of treatment with an antibacterial or within 2 weeks of an antisecretory drug (e.g. a proton pump inhibitor)
peritonitis post dialysis organism
Staphylococcus epidermidis.
UC most common site
rectum
triad of normocytic anaemia, thrombocytopenia and acute kidney injury.
Haemolytic uraemia syndrome
HUS most common cause (what bacteria) (1)
treatment (1)
E coli
supporitive (no Abx)
cancer Sx in coeliac disease
enteropathy-associated T cell lymphoma (EATL),
acute interstitial nephritis:
features? (1)
causes (4)
ffeawtures (4)
Acute interstitial nephritis causes an ‘allergic’ type picture consisting usually of raised urinary WCC and eosinophils, alongside impaired renal function
Classically urine shows elevated white cell counts and eosinophils. IgE is also often elevated.
drugs: the most common cause, particularly antibiotics
penicillin
rifampicin
NSAIDs
allopurinol
furosemide
systemic disease: SLE, sarcoidosis, and Sjogren’s syndrome
infection: Hanta virus , staphylococci
Features
fever, rash, arthralgia
eosinophilia
mild renal impairment
hypertension
Acute interstitial nephritis
histology (1)
investigations (2)
histology: marked interstitial oedema and interstitial infiltrate in the connective tissue between renal tubules
Investigations
sterile pyuria
white cell casts
CKD stage 1 and 2 diagnosis needs..
Some Sx/ features other than low eGFR
Oesophageal bleeding:
prophylaxis? (1)
acute management drug (1)
NS BB e.g. propranolol
Terlipressin is a vasopressin analogue that is indicated in the acute management of variceal bleeding.
(+ prophylactic Abx)
primary biliary cholangitis: Management (1)
associations (4)
urideoxycholic acid
(cholestyramine for the itch)
liver transplantation
e.g. if bilirubin > 100 (PBC is a major indication)
Associations
Sjogren’s syndrome (seen in up to 80% of patients)
rheumatoid arthritis
systemic sclerosis
thyroid disease
primary biliary cholagitis:
features (5)
early: may be asymptomatic (e.g. raised ALP on routine LFTs) or fatigue, pruritus
cholestatic jaundice
hyperpigmentation, especially over pressure points
around 10% of patients have right upper quadrant pain
xanthelasmas, xanthomata
also: clubbing, hepatosplenomegaly
late: may progress to liver failure
primary biliary cholangitis: complications (3)
Complications
cirrhosis → portal hypertension → ascites, variceal haemorrhage
osteomalacia and osteoporosis
significantly increased risk of hepatocellular carcinoma (20-fold increased risk)
Coeliac disese: WHAT biopsy?
JEJUNAL biopsy
Liver Hepatitis bloods
HBsAg = ongoing infection, either acute or chronic if present > 6 months
anti-HBc = caught, i.e. negative if immunized
Hepatic encepalopathy:
grading (4)
precipitating factors (5)
management (2)
Grade I: Irritability
Grade II: Confusion, inappropriate behaviour
Grade III: Incoherent, restless
Grade IV: Coma
infection e.g. spontaneous bacterial peritonitis
GI bleed
post transjugular intrahepatic portosystemic shunt
constipation
drugs: sedatives, diuretics
hypokalaemia
renal failure
increased dietary protein (uncommon)
1st= lactulose
2nd= Abx e.g. rifaximin
other options = protosystemic shunts/ liver transplant
Size of kidneys: CKD in diabetes?
AKI vs CKD?
other features differentiating CKD and AKI? (1)
Chronic diabetic nephropathy will have large/normal sized kidneys on ultrasound whereas most patients with chronic kidney disease have bilateral small kidneys
One of the best ways to differentiate between acute kidney injury (AKI) and chronic kidney disease (CKD) is renal ultrasound - most patients with CKD have bilateral small kidneys. Exceptions to this rule include:
autosomal dominant polycystic kidney disease
diabetic nephropathy (early stages)
amyloidosis
HIV-associated nephropathy
HYPOcalceamia = due to vit D = CKD
visible haematuria following a recent URTI
IgA nephropathy (Bergers disease)
Associated conditions
alcoholic cirrhosis
coeliac disease/dermatitis herpetiformis
Henoch-Schonlein purpura
IgA nephropathy and post-streptococcal glomerulonephritis
time difference?
protein and haematuria?
IgA= 1-2 days after URTI, PSGN= 1-2 weeks after
IgA= haematuria, PSGN= proteiuira AND haematuria
IgA= macroscopic haematuia, PSGN= low complement
Cholestatis +/ hepatitis: which drugs cause it?
combined oral contraceptive pill
antibiotics: flucloxacillin, co-amoxiclav, erythromycin*
anabolic steroids, testosterones
phenothiazines: chlorpromazine, prochlorperazine
sulphonylureas
fibrates
rare reported causes: nifedipine
which drugs cause liver cirrhosis
methotrexate
methyldopa
amiodarone
SBP:
most common organism? (1)
how to diagnose (1)
treatment (1)
prohplayxis? 91)
E coli
paracentesis (neutrophils >250)
IV cefotaxime
ABX : patients who have had an episode of SBP
patients with fluid protein <15 g/l and either Child-Pugh score of at least 9 or hepatorenal syndrome
NICE recommend: ‘Offer prophylactic oral ciprofloxacin or norfloxacin for people with cirrhosis and ascites with an ascitic protein of 15 g/litre or less until the ascites has resolved’
Primary biliary cholangitis - what rule
the M rule
IgM
anti-Mitochondrial antibodies, M2 subtype
Middle aged females
dyspepsia, abdominal pain, nausea and anorexia
Early symptoms of stomach cancer include:
All patients who’ve got an upper abdominal mass consistent with stomach cancer
Patients aged >= 55 years who’ve got weight loss, AND any of the following:
upper abdominal pain
reflux
dyspepsia
Non-urgent
Patients with haematemesis
Patients aged >= 55 years who’ve got:
treatment-resistant dyspepsia or
upper abdominal pain with low haemoglobin levels or
raised platelet count with any of the following: nausea, vomiting, weight loss, reflux, dyspepsia, upper abdominal pain
nausea or vomiting with any of the following: weight loss, reflux, dyspepsia, upper abdominal pain
Managing patients who do not meet referral criteria (‘undiagnosed dyspepsia’)
This can be summarised at a step-wise approach
1. Review medications for possible causes of dyspepsia
2. Lifestyle advice
3. Trial of full-dose proton pump inhibitor for one month OR a ‘test and treat’ approach for H. pylori
if symptoms persist after either of the above approaches then the alternative approach should be tried
Testing for H. pylori infection
initial diagnosis: NICE recommend using a carbon-13 urea breath test or a stool antigen test, or laboratory-based serology ‘where its performance has been locally validated’
test of cure:
there is no need to check for H. pylori eradication if symptoms have resolved following test and treat
however, if repeat testing is required then a carbon-13 urea breath test should be used
live screening for hepatocellular carcinoma is for who
Screening with ultrasound (+/- alpha-fetoprotein) should be considered for high risk groups such as:
patients liver cirrhosis secondary to hepatitis B & C or haemochromatosis
men with liver cirrhosis secondary to alcohol
Risk factors for HCC
alpha-1 antitrypsin deficiency
hereditary tyrosinosis
glycogen storage disease
aflatoxin
drugs: oral contraceptive pill, anabolic steroids
porphyria cutanea tarda
male sex
diabetes mellitus, metabolic syndrome